These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29634314)

  • 1. Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis.
    Kalavalapalli S; Bril F; Koelmel JP; Abdo K; Guingab J; Andrews P; Li WY; Jose D; Yost RA; Frye RF; Garrett TJ; Cusi K; Sunny NE
    Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E163-E173. PubMed ID: 29634314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.
    Sunny NE; Kalavalapalli S; Bril F; Garrett TJ; Nautiyal M; Mathew JT; Williams CM; Cusi K
    Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E311-9. PubMed ID: 26058864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis.
    Kalavalapalli S; Bril F; Guingab J; Vergara A; Garrett TJ; Sunny NE; Cusi K
    J Endocrinol; 2019 Jun; 241(3):293-305. PubMed ID: 31082799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity.
    Patterson RE; Kalavalapalli S; Williams CM; Nautiyal M; Mathew JT; Martinez J; Reinhard MK; McDougall DJ; Rocca JR; Yost RA; Cusi K; Garrett TJ; Sunny NE
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E484-94. PubMed ID: 26814015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.
    Krishnan A; Abdullah TS; Mounajjed T; Hartono S; McConico A; White T; LeBrasseur N; Lanza I; Nair S; Gores G; Charlton M
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G666-G680. PubMed ID: 28232454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice.
    Honda T; Ishigami M; Luo F; Lingyun M; Ishizu Y; Kuzuya T; Hayashi K; Nakano I; Ishikawa T; Feng GG; Katano Y; Kohama T; Kitaura Y; Shimomura Y; Goto H; Hirooka Y
    Metabolism; 2017 Apr; 69():177-187. PubMed ID: 28285648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.
    Gastaldelli A; Harrison SA; Belfort-Aguilar R; Hardies LJ; Balas B; Schenker S; Cusi K
    Hepatology; 2009 Oct; 50(4):1087-93. PubMed ID: 19670459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease.
    Shannon CE; Ragavan M; Palavicini JP; Fourcaudot M; Bakewell TM; Valdez IA; Ayala I; Jin ES; Madesh M; Han X; Merritt ME; Norton L
    Mol Metab; 2021 Mar; 45():101154. PubMed ID: 33359401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial pyruvate carrier inhibition initiates metabolic crosstalk to stimulate branched chain amino acid catabolism.
    Ferguson D; Eichler SJ; Yiew NKH; Colca JR; Cho K; Patti GJ; Shew TM; Lutkewitte AJ; Mukherjee S; McCommis KS; Niemi NM; Finck BN
    Mol Metab; 2023 Apr; 70():101694. PubMed ID: 36801448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitis.
    Duparc T; Briand F; Trenteseaux C; Merian J; Combes G; Najib S; Sulpice T; Martinez LO
    Am J Physiol Gastrointest Liver Physiol; 2019 Oct; 317(4):G508-G517. PubMed ID: 31460789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Branched-chain amino acids alter cellular redox to induce lipid oxidation and reduce de novo lipogenesis in the liver.
    Surugihalli C; Muralidaran V; Ryan CE; Patel K; Zhao D; Sunny NE
    Am J Physiol Endocrinol Metab; 2023 Apr; 324(4):E299-E313. PubMed ID: 36791321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD.
    Muyyarikkandy MS; McLeod M; Maguire M; Mahar R; Kattapuram N; Zhang C; Surugihalli C; Muralidaran V; Vavilikolanu K; Mathews CE; Merritt ME; Sunny NE
    FASEB J; 2020 Nov; 34(11):14832-14849. PubMed ID: 32918763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes.
    Bril F; Kalavalapalli S; Clark VC; Lomonaco R; Soldevila-Pico C; Liu IC; Orsak B; Tio F; Cusi K
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):558-566.e2. PubMed ID: 29223443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis.
    Zhang W; Xu YZ; Liu B; Wu R; Yang YY; Xiao XQ; Zhang X
    ScientificWorldJournal; 2014; 2014():603409. PubMed ID: 24558317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis.
    Verbeek J; Lannoo M; Pirinen E; Ryu D; Spincemaille P; Vander Elst I; Windmolders P; Thevissen K; Cammue BP; van Pelt J; Fransis S; Van Eyken P; Ceuterick-De Groote C; Van Veldhoven PP; Bedossa P; Nevens F; Auwerx J; Cassiman D
    Gut; 2015 Apr; 64(4):673-83. PubMed ID: 24917551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus: A Randomized Trial.
    Cusi K; Orsak B; Bril F; Lomonaco R; Hecht J; Ortiz-Lopez C; Tio F; Hardies J; Darland C; Musi N; Webb A; Portillo-Sanchez P
    Ann Intern Med; 2016 Sep; 165(5):305-15. PubMed ID: 27322798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S
    Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
    Li S; Li X; Chen F; Liu M; Ning L; Yan Y; Zhang S; Huang S; Tu C
    J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study.
    Bell LN; Wang J; Muralidharan S; Chalasani S; Fullenkamp AM; Wilson LA; Sanyal AJ; Kowdley KV; Neuschwander-Tetri BA; Brunt EM; McCullough AJ; Bass NM; Diehl AM; Unalp-Arida A; Chalasani N;
    Hepatology; 2012 Oct; 56(4):1311-8. PubMed ID: 22532269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.